UnknownNot Applicable

Genetic Diversity of Toxoplasma Gondii in Cancer Patients

Egypt100 participantsStarted 2020-06-01

Plain-language summary

I. Evaluation of T. gondii infection in cancer patients using different serological markers. II. Studying genetic lineages infecting cancer patients in Sohag Governorate to predict clinical course and therapeutic needs using B1 and RE genes.

Who can participate

Age range1 Year

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Hematologic cancers on treatment * Solid Cancers on treatment Exclusion Criteria: * Patients with other immune compromise states eg. DM, autoimmune diseases * Patients who are HIV positive

What they're measuring

Isolation and genotyping of T. gondii from blood of Cancer patients in Sohag Governorate, Egypt using PCR and DNA sequencing of Toxoplasma gondii B1 & RE genes.

Timeframe: up to 1 year

Evaluation of T. gondii infection in cancer patients using ELISA.

Timeframe: up to 1 year

Trial details

NCT IDNCT04834076

SponsorSohag University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-01-30

Contact for this trial

Eman FF Mohammed, Ass lecturer

201066209796 emanfathy@med.sohag.edu.eg

View on ClinicalTrials.gov More Toxoplasma Gondii Infection trials